USPTO serial 79183925
TUMORAD
Reviewed by CopyMark Law Group
Reg. 5043425Status 404
- Filing date
- Status date
- Registration date
- Sep 20, 2016
- Examiner
- MITTLER, ROBIN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TUMORAD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; chemical reagents for scientific purposes; chemical reagents for non-medical purposes | SECTION 71 - CANCELLED | — |
| 005 | Diagnostic preparations for medical or veterinary purposes; medical diagnostic reagents; x-ray contrast agents for medical purposes; radiological contrast substances for medical purposes; contrast media for use in medical imaging; anti-cancer preparations, namely, compounds for treating cancer; pharmaceutical preparations and products for the treatment of cancer; drug delivery agents in the form of nano-sized carriers that facilitate the delivery of pharmaceutical preparations, chemicals used in medicine and nanomedical applications, namely, chemical reagents for medical purposes and chemical preparations for pharmaceutical or medical purposes, namely, for treating cancer | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, scientific, laboratory, and medical research in the nature of chemistry and nanoscale discovery research, scientific laboratory services, industrial research in the field of medical technology; medical analysis, namely, quality measurement and analysis for medical practices; medical research services; biotechnology research services; research and development in the area of nano-medicine, cancer treatment and cancer diagnostics | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Spago Nanomedical AB
- Other trademarks owned by Spago Nanomedical AB
- Other trademarks owned by Spago Nanomedical AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named TUMORAD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 2, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jan 7, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 20, 2023 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 20, 2023 | INPC | INVALIDATION PROCESSED | — |
| Nov 30, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 31, 2023 | C71T | CANCELLED SECTION 71 | — |
| Apr 15, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 14, 2017 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 6, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 3, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 3, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 20, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 20, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 5, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 15, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 15, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 15, 2016 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 2, 2016 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jun 2, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 2, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 2, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 14, 2016 | RFNP | REFUSAL PROCESSED BY IB | — |
| May 10, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 10, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 4, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 4, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 3, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 2, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 15, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 10, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 3, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |